


Navigo Proteins Revenue
Biotechnology Research • Halle, Saxony-Anhalt, Germany • 51-100 Employees
Navigo Proteins revenue & valuation
| Annual revenue | $4,619,970 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $14,800,000 |
| Total funding | No funding |
Key Contact at Navigo Proteins
Kerstin Haucke
Director Intellectual Property, European Patent Attorney
Company overview
| Headquarters | Heinrich-Damerow-Str. 1, Halle/Saale, 06120, DE |
| Phone number | +4934527996332 |
| Website | |
| NAICS | 541714 |
| Keywords | Radiopharmaceuticals, Downstream Processing, Protein Engineering, Affinity Chromatography, Protein-Drug-Conjugates, Target Specific Delivery |
| Founded | 2017 |
| Employees | 51-100 |
| Socials |
Navigo Proteins Email Formats
Navigo Proteins uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@navigo-proteins.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@navigo-proteins.com | 100% |
About Navigo Proteins
Navigo Proteins discovers and develops novel scaffold proteins-based affinity ligands for commercial biologics GMP purification or as biopharmaceutical drugs/binders. They are all small, stable, highly engineerable, selective, and economically, homogeneously producible. In PRECISION CAPTURING a protein A-like scaffold serves for an antibody-like capture step even of non-Fc bearing molecules. In PRECISION TARGETING human ubiquitin is the basis for highly selective Affilin® ligands as part of a broad range of biopharmaceutical drugs. Navigo Proteins’ unique protein engineering expertise is the basis a world-wide unique, versatile scaffold proteins platform. Our robust, rapid and reliable high-throughput-based, robotics assisted platform designs, produces, analyzes and selects suitable affinity ligand proteins, optimized for their tasks in industrial downstream processing or as biopharmaceutical drugs. PRECISION CAPTURING creates custom ligands against any biologic, Fc-independent, and enables antibody-like affinity downstream processes, with competitive binding capacities, caustic stabilities, usage-cycles, flow rates and commercially available off-the-shelf leaching assays. It is applicable for purifying any recombinant protein, mAb, virus, VLP, cell, etc. Navigo Proteins has established partnerships worldwide to convert its custom affinity ligands into ready-to-use, GMP-compliant affinity resins for commercial downstream processing. Our PRECISION TARGETING platform creates tailored ligands which bind any desired biologic in biopharmaceutical or in diagnostic use, e.g. radiopharmaceuticals, Protein-drug-conjugates, CAR-T ligands or theranostics, in which the same Affilin® binder is employed in diagnosis, treatment and treatment-monitoring. Navigo Proteins is about 70 heads strong, steadily growing and based in Halle, S/W of Berlin. We offer our expertise to interested pharma, biotech and life sciences companies. https://www.navigo-proteins.com/imprint
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Navigo Proteins has 17 employees across 8 departments.
Departments
Number of employees
Funding Data
Navigo Proteins has never raised funding before.
Navigo Proteins Tech Stack
Discover the technologies and tools that power Navigo Proteins's digital infrastructure, from frameworks to analytics platforms.
Web servers
Cookie compliance
JavaScript libraries
Databases
Tag managers
Programming languages
Miscellaneous
Blogs
Page builders
Marketing automation
SEO
Mobile frameworks
Frequently asked questions
4.8
40,000 users



